Our study shows that NR1D1, PPP1R18, PGBD2, and PPP1R3D are effective as biomarkers in the diagnosis of myopia and that NR1D1, PPP1R18, PGBD2, and PPP1R3D may be potential therapeutic targets. The gene discussed is PPP1R18; the disease is myopia.